Veeva Systems Inc. (ETR:VEE)
186.20
-5.90 (-3.07%)
Apr 22, 2025, 5:35 PM CET
Veeva Systems Revenue
In the fiscal year ending January 31, 2025, Veeva Systems had annual revenue of $2.75B USD with 16.20% growth. Veeva Systems had revenue of $720.89M in the quarter ending January 31, 2025, with 14.31% growth.
Revenue
$2.75B
Revenue Growth
+16.20%
P/S Ratio
12.22
Revenue / Employee
$376.71K
Employees
7,291
Market Cap
32.28B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jan 31, 2025 | 2.75B | 382.95M | 16.20% |
Jan 31, 2024 | 2.36B | 208.61M | 9.68% |
Jan 31, 2023 | 2.16B | 304.28M | 16.44% |
Jan 31, 2022 | 1.85B | 385.71M | 26.33% |
Jan 31, 2021 | 1.47B | 360.99M | 32.70% |
Jan 31, 2020 | Pro | Pro | Pro |
Jan 31, 2019 | Pro | Pro | Pro |
Jan 31, 2018 | Pro | Pro | Pro |
Jan 31, 2017 | Pro | Pro | Pro |
Jan 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck KGaA | 21.16B |
Siemens Healthineers AG | 22.67B |
Fresenius SE & Co. KGaA | 21.83B |
Bayer Aktiengesellschaft | 46.61B |
Sartorius Aktiengesellschaft | 3.44B |
Fresenius Medical Care AG | 19.34B |
Carl Zeiss Meditec AG | 2.08B |
Fielmann Group AG | 2.16B |
Veeva Systems News
- 4 days ago - Peering Into Veeva Systems's Recent Short Interest - Benzinga
- 11 days ago - Veeva Systems: Substantially Overvalued As Growth Slows - Seeking Alpha
- 12 days ago - Flatiron Health Joins Veeva's Product Partner Program to Accelerate Oncology Clinical Research - Business Wire
- 27 days ago - Veeva Announces Research Site Clinical Trial Management System - PRNewsWire
- 4 weeks ago - What Does the Market Think About Veeva Systems? - Benzinga
- 5 weeks ago - Decoding Veeva Systems Inc (VEEV): A Strategic SWOT Insight - GuruFocus
- 5 weeks ago - Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen - Benzinga
- 5 weeks ago - Indero Marks 40th Study Live with Veeva RTSM - PRNewsWire